Report LibraryAll Reports
Datamonitor Healthcare CV&Met: Non-Alcoholic Steatohepatitis (NASH) Disease Coverage
Retail Price: $22,000.00*BioMedTracker Subscriber Price: $15,000.00 - click here to log in
December 21, 2017Non-alcoholic fatty liver disease (NAFLD) is a hepatic condition closely associated with metabolic syndrome, and non-alcoholic steatohepatitis (NASH) is a segment of NAFLD. Both NAFLD and NASH patients display hepatic steatosis, and do not drink more than recommended guideline amounts of alcohol. Hepatocellular injury may or may not be present in NAFLD patients; however, NASH is characterized by the presence of hepatocellular injury marked by hepatic steatosis, inflammation, and/or fibrosis.
This Datamonitor Healthcare Disease Coverage report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.
|Disease Group Covered:||Endocrine|